GBI Research, the leading
business intelligence provider, has released its latest research, "Type 2
Diabetes Therapeutics in Asia-Pacific Markets to 2020 - Increasing Uptake of
Novel Drug Classes to Drive Market Growth", which provides insights into
type 2 diabetes in the Asia-Pacific (APAC) markets of China, India, Japan and Australia.
The report estimates the market
size for 2013 and provides a forecast until 2020, and covers disease
epidemiology, treatment algorithms, and treatment use patterns. It also
provides in-depth analysis of the pipeline molecules, clinical trial failure
rates, and recent deals.
The report has been built using
data and information sourced from proprietary databases, primary and secondary
research and in-house analysis carried out by GBI Research's team of industry
experts.
Access
This Full Report @ http://www.radiantinsights.com/research/type-2-diabetes-therapeutics-in-asia-pacific-markets-to-2020-increasing-uptake-of-novel-drug-classes-to-drive-market-growth
In 2013, the value of the type 2
diabetes therapeutics market in APAC countries was an estimated $6.5 billion,
and it is forecast to grow at a Compound Annual Growth Rate (CAGR) of 7.1%
between 2013 and 2020 to $10.5 billion.
This strong growth is due to the
anticipated approval of products in relatively novel treatment classes, such as
Glucagon-Like Peptide-1 (GLP-1) agonists, Dipeptidyl Peptidase-4 (DPP-4)
inhibitors, and Sodium Glucose Transporter-2 (SGLT-2) inhibitors, as well as
the growth of the prevalence population in the APAC region, particularly in
India and China.
Scope
The report analyzes the treatment
use patterns, market characterization, pipeline analysis and key licensing and
co-development deals of the type 2 diabetes in the APAC markets of China,
India, Japan, and Australia.It includes -
- A brief introduction to type 2
diabetes, including its pathophysiology, etiology, diagnosis and treatment
algorithms
- In-depth analysis of currently
marketed drugs for type 2 diabetes, including analysis of their safety,
efficacy, treatment patterns, and strengths and weaknesses, as well as a heat
map comparing them in terms of safety and efficacy
- A comprehensive review of the
pipeline for type 2 diabetes, including individual analysis of a number of
late-stage pipeline drugs that are likely to enter the market during the
forecast period; the pipeline is analyzed by Phase distribution, molecule type,
program type, mechanism of action and molecular target
- Additional in-depth analysis of
pipeline drug clinical trials by Phase, trial size, trial duration and program
failure rate for each molecule type
- Multi-scenario market forecast
data to 2020, taking into account how the market might be affected by the
introduction of new drugs, the expiry of key patents on current drugs, and the
changes in disease epidemiology across the key developed markets
- Discussion of the drivers of
and barriers to market growth
- In-depth analysis of all
licensing and co-development deals that have occurred in the type 2 diabetes
market since 2006
Reasons
to buy
The report will enhance your
decision-making capability by allowing you to -
- Understand the type 2 diabetes
pipeline and the factors that indicate that it is becoming more innovative
- Examine detailed profiles for
promising pipeline products and gain an insight into how and with whom they are
likely to compete in the market
- Follow the trends in type 2
diabetes clinical trial size and duration in relation to industry averages
- Assess the potential risk of
future developmental programs for type 2 diabetes therapeutics, depending on
the mechanism of action, by taking into account the recorded clinical trial
failure rates
- Examine the growth patterns
expected for the type 2 diabetes market over the forecast period and the
countries that are expected to contribute the most to this growth, allowing you
to devise a more effectively tailored country strategy through an understanding
of key drivers and barriers
- Accelerate and strengthen your
market position by identifying key companies for strategic partnerships
About
Us
Radiant Insights is a platform
for companies looking to meet their market research and business intelligence
requirements. We assist and facilitate organizations and individuals procure
market research reports, helping them in the decision making process. We have a
comprehensive collection of reports, covering over 40 key industries and a host
of micro markets. In addition to over extensive database of reports, our
experienced research coordinators also offer a host of ancillary services such
as, research partnerships/ tie-ups and customized research solutions.
For
more information visit: Radiant
Insights
Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
Blog
URL: http://www.esorics2010.org/
No comments:
Post a Comment